InicioCarterasWatchlistComunidadDescubreScreener
NOT FOR DISTRIBUTION

Mycronic AB (publ)

Informe acción OM:MYCR

Capitalización de mercado: SEK 62.6b

  • Resumen empresa
    • Valoración
    • Crecimiento Futuro
    • Rendimiento pasado
    • Salud Financiera
    • Dividendos
  • Dirección
  • Propiedad
  • Información adicional
  • Comunidad de acciones

Mycronic Dividendos y recompras

Dividendo controles de criterios 3/6

Mycronic es una empresa que paga dividendos con una rentabilidad actual de 1.05% que está bien cubierta por los beneficios.

Información clave

1.1%

Rentabilidad por dividendo

0.03%

Rendimiento de la recompra

Rendimiento total para el accionista1.1%
Rendimiento futuro de los dividendos1.6%
Crecimiento de los dividendos12.8%
Próxima fecha de pago de dividendosn/a
Fecha ex dividendon/a
Dividendo por acciónn/a
Ratio de pago37%

Últimas actualizaciones de dividendos y recompras

Recent updates

User avatar
Actualización de narrativa • Sep 03

MYCR: Upgraded Rating And Raised Guidance Will Eventually Confront Rich Pricing

Analysts have lifted their price target for Mycronic to SEK 385, with an implied fair value move from SEK 211 to SEK 230. This reflects updated assumptions on discount rate, revenue growth, profit margin and future P/E, and it aligns with recent Street research where the stock was upgraded to Buy.
User avatar
Actualización de narrativa • Aug 17

MYCR: Upgraded Rating And 2026 Guidance Will Drive Revaluation Potential

Analysts have raised their price target on Mycronic from SEK 320 to SEK 385, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E multiples. What’s in the News for Mycronic Mycronic issued updated guidance for 2026.
User avatar
Actualización de narrativa • Aug 03

MYCR: Higher Guidance And Orders Will Face Lower Margin Pressure

Analysts have lifted their price target for Mycronic from SEK 161 to SEK 211, citing updated assumptions on growth, margins and P/E multiples, along with recent supportive Street research that includes a SEK 385 target. What’s in the News for Mycronic Mycronic received an SLX mask writer order from an existing customer in Asia, valued between US$5 million and US$7 million, with delivery planned for the second quarter of 2027.
User avatar
Actualización de narrativa • Jul 20

MYCR: Mixed Rating Shifts And Guidance Reset Will Shape Future Upside Potential

Analysts have raised their fair value estimate for Mycronic from SEK 260.25 to SEK 311.50, citing updated assumptions around revenue growth, profit margins, and a lower expected future P/E multiple, in the context of recent mixed broker views including a SEK 385 target from SEB Equities. Analyst Commentary Analyst views on Mycronic are mixed, with some taking a more constructive stance on the stock while others have turned more cautious.
User avatar
Actualización de narrativa • Jul 06

MYCR: Cautious Ratings And New Orders Will Shape Execution Focus

The analyst price target for Mycronic has been revised from SEK 255 to SEK 320, with analysts citing updated assumptions for revenue growth, profit margins and future P/E as they reassess the stock following a series of more cautious rating changes from SEB Equities, Nordea and DNB Carnegie. Analyst Commentary Recent commentary on Mycronic reflects a more cautious tone from several firms, yet the higher SEK 320 price target signals that some bullish analysts still see room for upside if the company delivers on the updated assumptions for revenue, margins and P/E.
User avatar
Actualización de narrativa • Jun 22

MYCR: Sector Downgrades And Execution Risks Will Restrain Future Upside

The latest Narrative Update on Mycronic reflects a reduced analyst price target of SEK260.25, as analysts factor in slightly lower revenue growth and profit margin assumptions, along with a modestly higher future P/E, in the context of several recent downgrades on the stock. Analyst Commentary Recent research on Mycronic points to a more cautious stance among several bearish analysts, who have downgraded the stock while reassessing revenue growth, margins, and valuation multiples.
Artículo de análisis • Jun 19

Mycronic (OM:MYCR) Stock Could Be 17.2% Overvalued After New SLX Order

Mycronic (OM:MYCR) stock is back in focus after the company reported a new European customer order for its SLX laser mask writer, valued at US$6 to 8 million with delivery planned in Q3 2026. See our latest analysis for Mycronic. The SLX order lands at a time when Mycronic’s short term share price momentum has been firm, with a 90 day share price return of 44.34%. The 1 year total shareholder return of 70.93% and 3 year total shareholder return of 151.03% point to strong long term...
User avatar
Actualización de narrativa • Jun 07

MYCR: Sector Downgrades And Higher Risk Perceptions Will Pressure Future Upside

Analysts have trimmed their stance on Mycronic, nudging the SEK 260.25 price target lower in line with a slightly higher discount rate and more cautious sector views following several recent rating downgrades. Analyst Commentary Recent research has taken a more cautious tone on Mycronic, with several downgrades pointing to higher required returns and more conservative sector assumptions feeding into valuation work.
User avatar
Actualización de narrativa • May 09

MYCR: Clustered Downgrades And Extended Deliveries Will Pressure Near Term Upside

The updated analyst price target for Mycronic has shifted from SEK 226.50 to SEK 260.25. Analysts cite changes in growth expectations and valuation assumptions, even as several firms have recently turned more cautious on the stock.
Artículo de análisis • Apr 29

Mycronic AB (publ) Just Missed Earnings - But Analysts Have Updated Their Models

It's been a good week for Mycronic AB (publ) ( STO:MYCR ) shareholders, because the company has just released its...
User avatar
Actualización de narrativa • Apr 24

MYCR: Extended Delivery Timeline For New Orders Will Restrain Near-Term Upside

Analysts have raised their price target on Mycronic to SEK226.50 from SEK213.67, reflecting updated views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. What's in the News Order for a customized SLX mask writer from a new customer, valued between US$27 million and US$30 million, with delivery planned in 2028.
User avatar
Actualización de narrativa • Apr 09

MYCR: Asian Equipment Orders And 2026 Outlook Will Support Steady Dividend Profile

Analysts have slightly adjusted their price target on Mycronic from SEK 215 to about SEK 214. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E multiples, while keeping their overall view broadly consistent.
User avatar
Actualización de narrativa • Mar 26

MYCR: Asian Orders And 2026 Guidance Will Underpin Stable Dividend Outlook

Analysts are maintaining their SEK 215.0 price target for Mycronic, noting only minor adjustments to inputs such as the discount rate, long-term revenue, profit margin and future P/E assumptions that do not materially change their valuation view. What's in the News Mycronic has issued earnings guidance for 2026, indicating expected net sales of SEK 8.25b for the period (Corporate Guidance).
User avatar
Actualización de narrativa • Mar 09

MYCR: Asian Orders And 2026 Guidance Will Support Steady Dividend Outlook

Analysts have maintained their SEK 215.00 price target for Mycronic. This reflects minor adjustments to assumptions regarding the discount rate, long-term growth and P/E, which did not meaningfully change their overall view of the shares.
User avatar
Actualización de narrativa • Feb 22

MYCR: Asian Orders And 2026 Guidance Will Shape Balanced Outlook

Analysts now keep their SEK 215.0 price target for Mycronic broadly unchanged, with slight adjustments in the discount rate, revenue growth expectations, profit margin assumptions, and future P/E multiples shaping the latest narrative update. What's in the News Mycronic issued earnings guidance for 2026, indicating expected net sales of SEK 8.25b for the period (company guidance).
Artículo de análisis • Feb 08

Analyst Estimates: Here's What Brokers Think Of Mycronic AB (publ) (STO:MYCR) After Its Full-Year Report

Mycronic AB (publ) ( STO:MYCR ) shareholders are probably feeling a little disappointed, since its shares fell 6.9% to...
User avatar
Actualización de narrativa • Feb 08

MYCR: Asian Orders And Higher Margins Will Support Bullish Outlook

Analysts have trimmed their price target on Mycronic to SEK215 from about SEK218.67, citing updated assumptions that include a slightly higher discount rate, adjusted revenue growth and profit margin expectations, and a lower future P/E multiple. What's in the News Mycronic announced an annual dividend of SEK 3.25 per share, with an ex dividend date set for May 7, 2026, a record date on May 8, 2026, and a payment date on May 13, 2026 (company announcement).
User avatar
Actualización de narrativa • Jan 24

MYCR: Asian Orders And Cautious Margins Will Support Stable Outlook

Analysts have kept their overall price target for Mycronic unchanged at SEK 218.67, with adjustments in the discount rate, profit margin and future P/E assumptions reflecting a more cautious margin outlook, offset by support from valuation multiples. What's in the News Mycronic received an order for an MMX metrology system from a new customer in Asia, valued in the range of US$2 million to US$4 million, with delivery planned for the current quarter (company announcement).
Artículo de análisis • Jan 23

Mycronic (STO:MYCR) Is Reinvesting To Multiply In Value

What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...
User avatar
Actualización de narrativa • Jan 08

MYCR: Asian Equipment Orders And Higher Margins Will Support Steady Outlook

Analysts have left their fair value estimate for Mycronic unchanged at SEK 218.67. The latest price target is shaped mainly by slightly revised assumptions on discount rate, revenue growth, profit margin and future P/E, which together reflect a more balanced view of the company’s earnings profile and valuation risk.
Artículo de análisis • Dec 31

Estimating The Fair Value Of Mycronic AB (publ) (STO:MYCR)

Key Insights Mycronic's estimated fair value is kr215 based on 2 Stage Free Cash Flow to Equity Current share price of...
User avatar
Actualización de narrativa • Dec 13

MYCR: Expanding Asian Orders Will Support Steady Earnings And Balanced Prospects

Analysts have nudged their price target for Mycronic slightly higher to approximately SEK 219 per share, reflecting modestly increased discount rate and future P E assumptions, while maintaining a generally stable view on long term revenue growth and profitability. What's in the News Mycronic secured a new Asian customer for its SLX semiconductor mask writer, an energy efficient system with an order value between USD 5 million and 7 million, with revenue recognized in the current quarter (company announcement).
User avatar
Actualización de narrativa • Nov 27

MYCR: Growing Asian Orders And Margins Will Support Measured Gains Through 2025

Analysts have slightly increased their price target for Mycronic to SEK 218.67 from SEK 217.33. They cite improved revenue growth expectations and a marginally higher projected profit margin.
User avatar
Actualización de narrativa • Nov 07

MYCR: Net Profit Margins And Orders Will Support Steady Outlook Through 2025

Analysts have slightly raised their price target for Mycronic from SEK 216.67 to SEK 217.33. They cite improved profit margin forecasts and a more favorable future price-to-earnings outlook.
Artículo de análisis • Oct 28

Mycronic AB (publ) Just Beat Revenue Estimates By 9.4%

Mycronic AB (publ) ( STO:MYCR ) just released its quarterly report and things are looking bullish. The company beat...
User avatar
Actualización de narrativa • Oct 24

Upcoming Orders and Expansion Will Drive Global Technology Reach Forward

Analyst Price Target Update for Mycronic Analysts have raised their fair value estimate for Mycronic from SEK 207.00 to SEK 216.67. This update reflects improved revenue growth projections, even though there is a slightly higher discount rate and lower profit margin expectations.
User avatar
Actualización de narrativa • Oct 10

Acquisitions And Launches Will Expand Global Technology Reach

Narrative Update on Mycronic: Analyst Price Target Revision Analysts have revised their price target for Mycronic downward by SEK 31, from SEK 238 to SEK 207. This adjustment is based on updated forecasts for slower revenue growth and slightly softer profit margins.
Artículo de análisis • Sep 19

Estimating The Fair Value Of Mycronic AB (publ) (STO:MYCR)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Mycronic fair value estimate is kr235 With kr220 share price...
User avatar
Actualización de narrativa • Aug 27

Acquisitions And Launches Will Expand Global Technology Reach

The increase in Mycronic's consensus price target to SEK238.00 reflects improved revenue growth forecasts and a modestly higher future P/E multiple. What's in the News Mycronic updated its 2025 revenue guidance, reverting to its original estimate of SEK 7.5 billion in net sales, compared to the previous range of SEK 7.0 to 7.5 billion.
User avatar
Nueva narrativa • Jun 24

Historically Cheap, but the Margin of Safety Is Still Thin

Electronics-complexity super-cycle — AI datacentres, EVs and advanced display / semiconductor nodes require ever-finer photomasks, ultra-precise die bonding and higher-reliability SMT lines, directly

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: El pago de dividendos de MYCR ha sido volátil en los últimos 10 años.

Dividendo creciente: El pago de dividendos de MYCR ha aumentado en los últimos 10 años.


Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de Mycronic vs. Mercado
¿Cómo se compara la rentabilidad por dividendo de MYCR con la del mercado?
SegmentoRentabilidad por dividendo
Empresa (MYCR)1.1%
Suelo de mercado 25% (SE)1.7%
Techo de mercado 25% (SE)4.3%
Media de la industria (Electronic)1.5%
Analista de previsiones (MYCR) (hasta 3 años)1.6%

Dividendo destacado: El dividendo de MYCR(1.05%) no es notable en comparación con el 25% inferior de pagadores de dividendos del mercado Swedish (1.69%).

Alto dividendo: El (1.05%) del dividendo de MYCR es bajo en comparación con el 25% de los principales pagadores de dividendos del mercado Swedish (4.32%).


Pago de beneficios a los accionistas

Cobertura de los beneficios: Con su razonablemente bajo ratio de pago (36.6%), los pagos de dividendos de MYCR están bien cubiertos por los beneficios.


Pago en efectivo a los accionistas

Cobertura de flujo de caja: Con su razonablemente bajo ratio de pago en efectivo (34.9%), los pagos de dividendos de MYCR están bien cubiertos por los flujos de caja.


Descubre empresas que pagan buenos dividendos

7D

1Y

7D

1Y

7D

1Y

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/09/14 20:07
Precio de las acciones al final del día2026/09/14 00:00
Beneficios2026/06/30
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
  • Formulario SEC 10-K
  • Formulario SEC 10-Q
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
  • Informes de análisis
  • Blue Matrix
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
  • Datos de mercado ICE
  • Formulario S-1 de la SEC
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
  • Formulario SEC 4
  • Formulario SEC 13D
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
  • Formulario SEC 10-K
  • Formulario SEC DEF 14A
Principales avances10 años
  • Anuncios de empresas
  • Formulario SEC 8-K

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Mycronic AB (publ) está cubierta por 9 analistas. 3 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Nils SjogrenABG Sundal Collier Sponsored
Oliver WongBofA Global Research
Mikael LaséenCarnegie Investment Bank AB

Toma mejores decisiones de inversión en cualquier lugar

Escanea para descargar
Abrir AppStoreAbrir Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Ver fuentes de datos
Mercados
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Ideas de inversión
  • Empresas infravaloradas
  • Potentes generadores de dividendos
  • Compras con información privilegiada
  • Energía nuclear
  • Vehículos autónomos
  • Inteligencia artificial
  • Criptomonedas y blockchain
  • Ciberseguridad
  • Más ideas
Comunidades de acciones
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Herramientas y funciones
  • Seguimiento de la cartera
  • Buscador de valores y alertas
  • Narrativas y Valores de Feria
  • Calculadora de dividendos
Noticias y descubrimientos
  • Últimas noticias de stock
  • Incidencias del mercado global
  • El Foxhole
  • Ideas de inversión
  • Narrativas de la comunidad
  • Qué hay de nuevo
Simply Wall St
  • Planes y precios
  • Publicidad
  • Quiénes somos
  • Contacte con nosotros
  • Empleos
  • Centro de ayuda
  • Aprender a invertir en bolsa
  • Programa de afiliados
  • Empresas y negocios
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Términos y condiciones de uso
  • Política de privacidad
  • Términos de IA
  • Guía de servicios financieros